Jama Pitman
Corporate Officer/Principal chez DECIPHERA PHARMACEUTICALS, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Jama Pitman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2015 | - |
| Conseiller Juridique Général | 01/01/2015 | - |
Historique de carrière de Jama Pitman
Formation de Jama Pitman
| University of New Hampshire | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Jama Pitman
- Expérience
